Pyxis Oncology raises $152m in Series B round for cancer therapies

pallavi123- March 30, 2021

Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More

Aura Biosciences raises $80m for VDC therapies for cancers

pallavi123- March 22, 2021

Aura Biosciences, a portfolio company of UK-based Arix Bioscience, has raised $80 million in a new funding round for developing virus-like drug conjugate (VDC) therapies ... Read More